Wouter Van’t Hof

1.7k total citations
44 papers, 1.3k citations indexed

About

Wouter Van’t Hof is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Wouter Van’t Hof has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 20 papers in Genetics and 13 papers in Immunology. Recurrent topics in Wouter Van’t Hof's work include Mesenchymal stem cell research (19 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Tissue Engineering and Regenerative Medicine (8 papers). Wouter Van’t Hof is often cited by papers focused on Mesenchymal stem cell research (19 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Tissue Engineering and Regenerative Medicine (8 papers). Wouter Van’t Hof collaborates with scholars based in United States, Netherlands and Canada. Wouter Van’t Hof's co-authors include Robert Deans, Ronald G. Crystal, Gerrit van Meer, Jef Pinxteren, Marilyn D. Resh, Anthony E. Ting, Juliana Woda, Amy Raber, Timothy Fong and Enrique Rodríguez-Boulan and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Blood.

In The Last Decade

Wouter Van’t Hof

43 papers receiving 1.2k citations

Peers

Countries citing papers authored by Wouter Van’t Hof

Since Specialization

Citations

This map shows the geographic impact of Wouter Van’t Hof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter Van’t Hof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter Van’t Hof more than expected).

Fields of papers citing papers by Wouter Van’t Hof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter Van’t Hof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter Van’t Hof. The network helps show where Wouter Van’t Hof may publish in the future.

Co-authorship network of co-authors of Wouter Van’t Hof

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter Van’t Hof. A scholar is included among the top collaborators of Wouter Van’t Hof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter Van’t Hof. Wouter Van’t Hof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insights into highly engraftable hematopoietic cells from 27-year cryopreserved umbilical cord blood 2023 ·Cell Reports Medicine ·Hal E. Broxmeyer, Larry L. Luchsinger, Rona Singer Weinberg, (unknown), (unknown), Wouter Van’t Hof, Maegan L. Capitano, Christopher D. Hillyer, Mark H. Kaplan, Scott Cooper, James Ropa	5
2	Local Oxygen Dictates Hematopoietic Cell Growth and Function 2023 ·Blood ·James Ropa, (unknown), (unknown), (unknown), Wouter Van’t Hof, Mark H. Kaplan, Maegan L. Capitano	1
3	UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities 2022 ·Transplantation and Cellular Therapy ·Maude Dumont-Lagacé, (unknown), (unknown), (unknown), Wouter Van’t Hof, (unknown), Guy Sauvageau, Sandra Cohen	16
4	Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability 2021 ·Scientific Reports ·Jeong‐su Do, Daniel B. Zwick, Jonathan Kenyon, Fei Zhong, David S. Askew, Alex Y. Huang, Wouter Van’t Hof, (unknown), Mary J. Laughlin	27
5	Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike Protein 2020 ·Stem Cell Reviews and Reports ·James Ropa, Scott Cooper, Maegan L. Capitano, Wouter Van’t Hof, Hal E. Broxmeyer	59
6	Automatic Stem Cell Detection in Microscopic Whole Mouse Cryo-Imaging 2015 ·IEEE Transactions on Medical Imaging ·(unknown), Madhusudhana Gargesha, Wouter Van’t Hof, Kenneth R. Cooke, David L. Wilson	17
7	Culturing Protocols for Human Multipotent Adult Stem Cells 2014 ·Methods in molecular biology ·Bart Vaes, (unknown), (unknown), (unknown), Robert Deans, Jef Pinxteren, Wouter Van’t Hof	5
8	Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial 2014 ·Biology of Blood and Marrow Transplantation ·Richard T. Maziarz, Timothy Devos, Carlos Bachier, Steven C. Goldstein, José F. Leis, Steven M. Devine, Gabrielle Meyers, James Gajewski, Johan Maertens, Robert Deans, Wouter Van’t Hof, Hillard M. Lazarus	44
9	Human multipotent adult progenitor cells transcriptionally regulate fucosyltransferase VII 2013 ·Cytotherapy ·Gregory G. Burrows, Richard T. Maziarz, (unknown), Nicholas Lehman, Amy Raber, Robert Deans, Wouter Van’t Hof	5
10	Application of MultiStem® Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease 2012 ·Frontiers in Immunology ·Bart Vaes, Wouter Van’t Hof, Robert Deans, Jef Pinxteren	55
11	Development of a surrogate angiogenic potency assay for clinical-grade stem cell production 2012 ·Cytotherapy ·Nicholas Lehman, Rochelle Cutrone, Amy Raber, R.R. Perry, Wouter Van’t Hof, Robert Deans, Anthony E. Ting, Juliana Woda	49
12	Regenerative Stromal Cell Therapy in Allogeneic Hematopoietic Stem Cell Transplantation: Current Impact and Future Directions 2009 ·Biology of Blood and Marrow Transplantation ·Jeffery J. Auletta, Kenneth R. Cooke, Luis A. Solchaga, Robert Deans, Wouter Van’t Hof	33
13	Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease 2008 ·Cellular Immunology ·Magdalena Kovacsovics‐Bankowski, Philip R. Streeter, (unknown), Mark R. Frey, Amy Raber, Wouter Van’t Hof, Robert Deans, Richard T. Maziarz	41
14	Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells 2008 ·Cytotherapy ·Magdalena Kovacsovics‐Bankowski, (unknown), Amy Raber, (unknown), R. Deans, (unknown), Wouter Van’t Hof	31
15	Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct 2007 ·Cytotherapy ·Wouter Van’t Hof, Niladri Mal, Yan Huang, (unknown), Zoran Popović, Farhad Forudi, R. Deans, Marc S. Penn	43
16	Therapeutic pathways of adult stem cell repair 2007 ·Critical Reviews in Oncology/Hematology ·Anthony E. Ting, Robert W. Mays, Mark R. Frey, Wouter Van’t Hof, Satish Medicetty, Robert Deans	34
17	Analysis of Myristoylated and Palmitoylated Src Family Proteins 2003 ·Humana Press eBooks ·(unknown), Wouter Van’t Hof, Marilyn D. Resh	4
18	Manipulation of the Cytoplasmic and Transmembrane Domains Alters Cell Surface Levels of the Coxsackie–Adenovirus Receptor and Changes the Efficiency of Adenovirus Infection 2001 ·Human Gene Therapy ·Wouter Van’t Hof, Ronald G. Crystal	22
19	Targeting proteins to plasma membrane and membrane microdomains by N-terminal myristoylation and palmitoylation 2000 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Wouter Van’t Hof, Marilyn D. Resh	23
20	Glycosphingolipid clusters and the sorting of GPI-anchored proteins in epithelial cells. 1994 ·PubMed ·Chiara Zurzolo, Wouter Van’t Hof, Gerrit van Meer, Enrique Rodríguez-Boulan	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact